Insider · CIK 0001927648

Burkhart Erin

Reports to the SEC for 2 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001927648

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-22	GILDGILEAD SCIENCES, INC.F Tax Payment	SVP, Controllership	FTax Payment	−768 sh	$152.67	−$117K	1,455
2026-09-22	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	SVP, Controllership	MExercise/Conversion	−2,223 sh	—	—	9,022
2026-09-22	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	SVP, Controllership	MExercise/Conversion	+2,223 sh	—	—	2,223
2026-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	SVP, Controllership	AAward	+2,355 sh	—	—	11,245
2026-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	SVP, Controllership	AAward	+5,455 sh	—	—	5,455
2025-09-22	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	SVP, Controllership	AAward	+8,890 sh	—	—	8,890
2025-05-20	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	GVP, Chief Accounting Officer	SSale	−1,786 sh	$59.31	−$106K	14,173
2025-05-19	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	GVP, Chief Accounting Officer	FTax Payment	−996 sh	$59.27	−$59K	15,959
2025-03-19	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	GVP, Chief Accounting Officer	SSale	−1,295 sh	$71.52	−$92.6K	16,955
2025-03-17	BMRNBIOMARIN PHARMACEUTICAL INCA Award	GVP, Chief Accounting Officer	AAward	+5,970 sh	—	—	18,252
2025-03-17	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	GVP, Chief Accounting Officer	AAward	+9,230 sh	—	—	9,230
2025-03-14	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	GVP, Chief Accounting Officer	FTax Payment	−823 sh	$69.44	−$57.1K	12,282
2025-02-24	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	GVP, Chief Accounting Officer	SSale	−1,344 sh	$68.38	−$91.9K	13,105
2024-08-13	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	GVP, Chief Accounting Officer	SSale	−714 sh	$90.00	−$64.3K	14,449
2024-05-17	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	GVP, Chief Accounting Officer	FTax Payment	−993 sh	$76.97	−$76.4K	15,163
2024-04-10	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	GVP, Chief Accounting Officer	SSale	−2,286 sh	$90.00	−$206K	16,156
2024-03-18	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	GVP, Chief Accounting Officer	FTax Payment	−372 sh	$83.87	−$31.2K	18,442
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	GVP, Chief Accounting Officer	AAward	+4,720 sh	—	—	18,814
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	GVP, Chief Accounting Officer	AAward	+7,050 sh	—	—	7,050
2023-05-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	GVP, Chief Accounting Officer	FTax Payment	−796 sh	$92.02	−$73.2K	14,094
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	GVP, Chief Accounting Officer	AAward	+3,760 sh	—	—	14,890
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	GVP, Chief Accounting Officer	AAward	+5,720 sh	—	—	5,720
2022-05-16	BMRNBIOMARIN PHARMACEUTICAL INCA Award	GVP, Chief Accounting Officer	AAward	+11.1K sh	—	—	11,130
2022-05-16	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	GVP, Chief Accounting Officer	AAward	+17.5K sh	—	—	17,490

Recent filings

Accepted (ET)
Sep 234
Burkhart Erin0001927648-26-000005
SEC(opens sec.gov)
Mar 124
Burkhart Erin0001927648-26-000002
SEC(opens sec.gov)
Sep 234
Burkhart Erin0001927648-25-000009
SEC(opens sec.gov)
May 204
Burkhart Erin0001048477-25-000060
SEC(opens sec.gov)
Mar 204
Burkhart Erin0001048477-25-000041
SEC(opens sec.gov)
Mar 184
Burkhart Erin0001048477-25-000039
SEC(opens sec.gov)
Feb 254
Burkhart Erin0001048477-25-000009
SEC(opens sec.gov)
Aug 154
Burkhart Erin0001048477-24-000128
SEC(opens sec.gov)
May 204
Burkhart Erin0001048477-24-000084
SEC(opens sec.gov)
Apr 124
Burkhart Erin0001048477-24-000061
SEC(opens sec.gov)
Mar 194
Burkhart Erin0001048477-24-000050
SEC(opens sec.gov)
May 184
Burkhart Erin0001209191-23-030736
SEC(opens sec.gov)

Companies

Address

333 LAKESIDE DRIVE

FOSTER CITY, CA, 94404